glp 1 drugs and crohn's disease Ozempic Disease: Could GLP-1s Help? The alleviating effect and mechanism
Description
doi: 10.1210/jc.2011-0266 8 LindgrenOPaciniGTuraAHolstJJDeaconCFAhrnBet al
In the USA, an estimated 5 million patients suffer from some form of gastroparesis [23], and the female:male ratio is 4:1 [24, 25]
It not only successfully regulates blood sugar levels [1] but also reduces the appetite and, thereby, the weight of patients [2], especially in individuals with obesity and type 2 diabetes mellitus (T2DM)
Dahl D, Onishi Y, Norwood P et al (2022) Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial
Long-acting glucagon-like peptide-1 receptor agonists suppress voluntary alcohol intake in male wistar rats
